Category: Congress Info

Abstracts Book of Targeting Phage Therapy 2024 is Now Available

Posted on by Targeting Phage Therapy
The Targeting Phage Therapy 2024 Abstract Book has been released.  You can now gain access to the abstracts of 40 communications, featuring major talks, short orals, and posters, highlighting advancements in phage therapy. Phage Therapy 2024 Communications You can learn more about the communications in the conference program: www.phagetherapy-site.com/Program. How to Access Abstracts Book Order…
Posted on June 11, 2024
Read More
Advances in Phage Therapy and Antimicrobial Strategies: Insights from Oral Presentations 2024

Advances in Phage Therapy and Antimicrobial Strategies: Insights from Oral Presentations 2024

Posted on by Targeting Phage Therapy
The rising threat of antibiotic-resistant bacterial infections has spurred extensive research into alternative therapeutic strategies. Bacteriophages (phages), viruses that infect bacteria, have emerged as a promising tool in combating resistant pathogens. The recent collection of oral presentations provides a comprehensive overview of the latest advancements in phage therapy and antimicrobial research. Oral Presentation Summaries and…
Posted on June 10, 2024
Read More
DOI Allocation for Targeting Phage Therapy 2024 Abstracts

DOI Allocation for Targeting Phage Therapy 2024 Abstracts

Posted on by Targeting Phage Therapy
It is a great pleasure to announce that all abstracts submitted to the 7th World Conference on Targeting Phage Therapy will be included in the Abstracts Book 2024, assigned with a DOI (Digital Object Identifier). Why a DOI? A DOI ensures that your abstracts are indexed on major academic platforms such as ORCID, Google Scholar,…
Posted on June 5, 2024
Read More
Selected Poster Presentation – Targeting Phage Therapy 2024

Selected Poster Presentation – Targeting Phage Therapy 2024

Posted on by Targeting Phage Therapy
The rising threat of antibiotic-resistant bacterial infections has spurred extensive research into alternative therapeutic strategies. Bacteriophages (phages), viruses that infect bacteria, have emerged as a promising tool in combating resistant pathogens. Poster Summaries and Scientific Impacts 1. Development of Phage-based Tool with the Potential to Treat Antibiotic-Resistant Gonorrhea Magdalena Pelka, University of Warsaw, Poland The…
Posted on June 4, 2024
Read More
Meet the Industries Attending Targeting Phage Therapy 2024

Meet the Industries Attending Targeting Phage Therapy 2024

Posted on by Targeting Phage Therapy
Targeting Phage Therapy 2024 gathered 15+ key players in the phage therapy industry to showcase. Participants engaged in meaningful discussions on the latest research, regulatory landscapes, and successful case studies in phage therapy.  Attendees had the opportunity to learn about advancements in phage selection, manufacturing, and production, which are crucial for the development and implementation…
Posted on June 4, 2024
Read More

Dr. Schooley’s call to action: Elevating phage therapy trials through strategic translational research

Posted on by Targeting Phage Therapy
The 7th World Conference on Targeting Phage Therapy was organized on June 20-21, 2024 at Corinthia Palace Malta. Robert T. Schooley, M.D., Professor of Medicine at the University of California, San Diego, and Co-Director of the Center for Innovative Phage Applications and Therapeutics and member of the Executive Committee for the University of California Disaster…
Posted on March 13, 2024
Read More
The Concluding Remarks of Targeting Phage Therapy 2023 & Future Perspectives

The Concluding Remarks of Targeting Phage Therapy 2023 & Future Perspectives

Posted on by Targeting Phage Therapy
The 6th World Congress on Targeting Phage Therapy 2023 that was held on June 1-2 in Paris, and gathered more than 150 attendees from 30+ different countries. Targeting Phage Therapy 2023 included more than 71 presentations between major talks, short orals, and posters. The Chairman of the scientific committee Dr. Marvin Edeas Université de Paris,…
Posted on June 9, 2023
Read More
Phage Therapy 2023 Best Short Oral: Bacteriophage-Antibiotic Combination to Allow Liver Transplantation

Phage Therapy 2023 Best Short Oral: Bacteriophage-Antibiotic Combination to Allow Liver Transplantation

Posted on by Targeting Phage Therapy
The Targeting Phage Therapy 2023 Best Short Oral Presentation award was discerned to: Bacteriophage-Antibiotic Combination Therapy Against Extensively Drug-Resistant Pseudomonas Aeruginosa Infection to Allow Liver Transplantation in a Toddler Brieuc Van Nieuwenhuyse, UC Louvain, Belgium Dr. Van Nieuwenhuyse explained to Targeting Phage Therapy: “My research focuses on bidirectional translational research, trying to analyze specific mechanisms…
Posted on June 5, 2023
Read More
Targeting Phage Therapy 2023 Best Poster: Thermostable Bactericidal Endolysin Discovery

Targeting Phage Therapy 2023 Best Poster: Thermostable Bactericidal Endolysin Discovery

Posted on by Targeting Phage Therapy
The Targeting Phage Therapy 2023 Best Poster Presentation award was discerned to: New Ways to Fight Bacterial Pathogens: Metagenomics Analysis for the Discovery of a Thermostable Endolysin With High Bactericidal Activity Panagiota Pantiora, Agricultural University of Athens, Greece Ms. Pantiora is currently a PhD student in Enzyme Biotechnology, at the Laboratory of Enzyme Technology of AUA,…
Posted on June 5, 2023
Read More
Phiogen CEO was awarded the Phage Therapy 2023 Best Innovation for their technology platform

Phiogen CEO was awarded the Phage Therapy 2023 Best Innovation for their technology platform

Posted on by Targeting Phage Therapy
The Targeting Phage Therapy 2023 Best Scientific Contribution award was discerned to: Amanda (Curtis) Burkardt, CEO of PHIOGEN, USA Ms. Burkardt was awarded for creating patient ready products in a remedy ready world. Spun-off from of one of the US’s only phage therapy cores, TAILOR Labs at Baylor College of Medicine, an ambitious new biotech…
Posted on June 3, 2023
Read More